Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133.
- Resource Type
- Article
- Source
Scientific Reports . 10/31/2018, Vol. 8 Issue 1, p1-15. 15p.- Subject
- Language
- ISSN
- 2045-2322